Ayson, Flora Mae C.
HRN: 17-57-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2025
CEFUROXIME 500MG (TAB)
06/18/2025
06/25/2025
ORAL
500 Mg/tab
Bid
Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes